Skip Navigation LinksHome > August 2012 - Volume 34 - Issue 6 > Reactivation of Chagas Disease by Immunosuppressive Therapy...
Text sizing:
American Journal of Dermatopathology:
doi: 10.1097/DAD.0b013e318257f9e2
Extraordinary Case Report

Reactivation of Chagas Disease by Immunosuppressive Therapy in a Patient With Systemic Lupus Erythematosus: Report of an Exceptional Case

Burgos, Lourdes Gonzalez MD*; Ortiz, Beatriz Di Martino MD*; Canese, Andrés MD; Ojeda, Aldo MD; Melo, Marcia MD

Collapse Box


Abstract: Chagas disease is a zoonosis caused by the protozoan Trypanosoma cruzi. It presents as a chronic evolution and produces high morbidity and mortality in countries where the disease is endemic, as in ours. The skin disease is very rare and results from the reactivation of latent disease as a result of immunosuppression, presenting with acute, atypical, and severe lesions. We describe the case of a patient who was unaware of being a carrier of Chagas disease and presented reactivation after immunosuppressive therapy instituted to treat her systemic lupus erythematosus.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.